Hyporesponsiveness of peripheral blood lymphocytes to streptococcal superantigens in patients with guttate psoriasis:: evidence for systemic stimulation of T cells with superantigens released from focally infecting Streptococcus pyogenes

被引:12
作者
Tokura, Y
Seo, N
Ohshima, A
Wakita, H
Yokote, R
Furukawa, F
Takigawa, M
机构
[1] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan
[2] Natl Takasaki Hosp, Dermatol Sect, Takasaki, Gumma 370, Japan
关键词
psoriasis; streptococcus; superantigens; T cell;
D O I
10.1007/s004030050426
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Throat infection with Streptococcus pyogenes is the most important trigger for acute guttate psoriasis. We examined the in vitro responses of peripheral blood mononuclear cells (PBMC) to streptococcal superantigens, SPEA and SPEC, and staphylococcal superantigens, SEE and TSST-1, in patients with guttate psoriasis, in patients with chronic plaque psoriasis, and in healthy subjects. PBMC from patients with guttate psoriasis responded poorly to SPEA and SPEC at concentrations of 0.1 and 1 ng/ml as compared with those from patients with plaque psoriasis, but showed high responses to SEE and TSST-1. The hyporesponsiveness recovered after improvement of the skin eruption. There was no significant difference between guttate and chronic types of psoriasis in the percentage of circulating T-cell receptor BV2 or BV8-bearing T cells, responsive to streptococcal superantigens, indicating that T-cell clonal anergy was a mechanism underlying the hyporesponsiveness. Our results suggest that superantigens released from focally infecting S. pyogenes induce a transient activation of relevant T cells, leading to the development of skin eruption and, subsequently, temporary T-cell anergy to these toxins.
引用
收藏
页码:382 / 389
页数:8
相关论文
共 43 条
[1]  
BAKER BS, 1984, BRIT J DERMATOL, V110, P555
[2]   T-CELL-RECEPTOR REPERTOIRE IN CHRONIC PLAQUE-STAGE PSORIASIS IS RESTRICTED AND LACKS ENRICHMENT OF SUPERANTIGEN-ASSOCIATED V-BETA REGIONS [J].
BOEHNCKE, WH ;
DRESSEL, D ;
MANFRAS, B ;
ZOLLNER, TM ;
WETTSTEIN, A ;
BOHM, BO ;
STERRY, W .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (05) :725-728
[3]  
BOUR H, 1995, ACTA DERM-VENEREOL, V75, P218
[4]   Antigen receptor β chain variable region usage by CD4+ and CD8+ T cells in psoriasis [J].
Camp, RDR ;
Vekony, MA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (06) :987-988
[5]   CD8+ T-CELLS IN PSORIATIC LESIONS PREFERENTIALLY USE T-CELL RECEPTOR V(BETA)3 AND/OR V(BETA)13.1 GENES [J].
CHANG, JCC ;
SMITH, LR ;
FRONING, KJ ;
SCHWABE, BJ ;
LAXER, JA ;
CARALLI, LL ;
KURLAND, HH ;
KARASEK, MA ;
WILKINSON, DI ;
CARLO, DJ ;
BROSTOFF, SW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9282-9286
[6]   SUPERANTIGENS AND PSEUDOSUPERANTIGENS OF GRAM-POSITIVE COCCI [J].
FLEISCHER, B ;
GERLACH, D ;
FUHRMANN, A ;
SCHMIDT, KH .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1995, 184 (01) :1-8
[7]   SEVERE PSORIASIS - ORAL THERAPY WITH A NEW RETINOID [J].
FREDRIKSSON, T ;
PETTERSSON, U .
DERMATOLOGICA, 1978, 157 (04) :238-244
[8]  
Furukawa Fukumi, 1996, Journal of Dermatology (Tokyo), V23, P670
[9]   RESPONSE OF PSORIASIS TO A LYMPHOCYTE-SELECTIVE TOXIN (DAB(389)IL-2) SUGGESTS A PRIMARY IMMUNE, BUT NOT KERATINOCYTE, PATHOGENIC BASIS [J].
GOTTLIEB, SL ;
GILLEAUDEAU, P ;
JOHNSON, R ;
ESTES, L ;
WOODWORTH, TG ;
GOTTLIEB, AB ;
KRUEGER, JG .
NATURE MEDICINE, 1995, 1 (05) :442-447
[10]  
GRIFFITHS CEM, 1992, SPRINGER SEMIN IMMUN, V13, P441